Waltermire Robert E. — SEC Form 4 filings
SEC reporting owner CIK 1876996. 9 Form 4 filings on record with FilingPulse; latest filed 2025-03-07.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-01-18 to 2025-03-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 16 legs across 7 filings — 20,821 shares, $6,732,637 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 4,701 shares @ $343.85 ($1,616,429) in MADRIGAL PHARMACEUTICALS, INC., filed 2025-03-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Senior VP, Chief Pharma Dev. | 9 | — | 16 legs · 20,821 sh · $6,732,637 | 14 |
Form 4 filings — Waltermire Robert E.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-03-07 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 6,825 @ $87.92 · Option exercise (M): 7,288 @ $87.09 · Sale (S): 900 @ $335.15 · Sale (S): 1,777 @ $336.78 · Sale (S): 1,146 @ $338.09 · Sale (S): 400 @ $339.68 · +9 more | EDGAR |
| 2025-03-04 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale (S): 1,052 @ $340.99 · Sale (S): 175 @ $341.55 | EDGAR |
| 2025-01-27 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale (S): 103 @ $335.24 | EDGAR |
| 2025-01-17 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale (S): 442 @ $273.41 | EDGAR |
| 2024-06-18 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 1,900 @ $87.09 · Sale (S): 1,900 @ $280 · Option exercise (M): 1,900 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Option exercise (M): 2,000 @ $87.92 · Sale (S): 2,000 @ $285 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale (S): 1,036 @ $231.34 | EDGAR |
| 2024-01-25 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 1,419 @ $0 · Grant/award (A): 2,138 (derivative) @ $0 · Grant/award (A): 1,419 (derivative) @ $0 | EDGAR |
| 2024-01-18 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Tax withholding (F): 550 @ $243.92 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1876996 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →